Recent Clinical Trials 2024 Uk Andy Amelina The first drug found to slow down Alzheimer’s is to be given the green light for use in Britain Lecanemab, hailed by experts as “the beginning of the end” for the disease, has been found to slow The latest audit shines a stark light on the urgent challenges and immense pressures confronting people using, and working in, memory services
Answering Your Questions About Aducanumab Alzheimer S Research Uk After a long process, not free of controversy, a task force convened by the Alzheimer's Association has outlined criteria to facilitate clinical research, and to assist clinicians in the evaluation of The pathophysiological process of Alzheimer's disease in clinical trials of AD therapeutic agents, as well as the limitations of this promising imaging technique Disclsoure: This research New research is contradicting previously held views that only neurons secret beta-amyloid that forms toxic plaques, a marker of Alzheimer's disease in the brain The study points to another culprit: Removing clinical trial requirements for cutting-edge therapies could be a first step towards increasing accessibility for those who need it most
Comments are closed.